ELIQUIS 5 MG APIXABAN TABLETS

ELIQUIS 5 mg Tablets contain Apixaban, a widely trusted and clinically proven anticoagulant designed to reduce the risk of harmful blood clots. As a Direct Oral Anticoagulant (DOAC), Apixaban works by selectively inhibiting Factor Xa, a key enzyme responsible for clot formation. By targeting this pathway, ELIQUIS helps lower the risk of stroke, systemic embolism, deep vein thrombosis, and pulmonary embolism in individuals who require ongoing clot-prevention therapy under medical supervision.

The 5 mg strength is the standard therapeutic dose for most adults, offering reliable, predictable anticoagulation without the need for routine INR monitoring. ELIQUIS is well-known for its favorable safety profile, consistent absorption, and minimal dietary restrictions compared to older anticoagulants. This makes it a preferred choice for long-term blood clot prevention in appropriate patients, especially those with certain heart rhythm conditions or a history of clotting events.

Manufactured with strict pharmaceutical quality standards, ELIQUIS 5 mg Tablets ensure purity, potency, and dependable performance with every dose. Their easy-to-swallow design integrates seamlessly into daily routines, supporting consistent adherence and stable anticoagulation for long-term cardiovascular protection.

Key Benefits

Reduces Risk of Harmful Blood Clots:
Helps prevent conditions such as deep vein thrombosis and pulmonary embolism by inhibiting clot formation at the source.

Lowers Stroke Risk in Eligible Individuals:
Clinically proven to reduce stroke risk, especially in people with certain heart rhythm abnormalities like atrial fibrillation.

Provides Predictable Anticoagulation:
Offers steady, reliable blood-thinning effects without the frequent testing required for older therapies.

Key Features

Standard 5 mg Dose:
The commonly prescribed strength for adults requiring consistent anticoagulant protection.

Pharmaceutical-Grade Quality:
Produced under rigorous manufacturing standards to ensure safety, potency, and trusted daily performance.

Twice-Daily Administration:
Designed for predictable absorption and stable anticoagulant effect throughout the day.